Portolan Capital Management, LLC Pure Tech Health PLC Transaction History
Portolan Capital Management, LLC
- $1.38 Billion
- Q2 2025
A detailed history of Portolan Capital Management, LLC transactions in Pure Tech Health PLC stock. As of the latest transaction made, Portolan Capital Management, LLC holds 27,795 shares of PRTC stock, worth $486,412. This represents 0.03% of its overall portfolio holdings.
Number of Shares
27,795
Previous 11,885
133.87%
Holding current value
$486,412
Previous $235,000
103.83%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding PRTC
# of Institutions
9Shares Held
353KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC243KShares$4.25 Million0.19% of portfolio
-
Pentwater Capital Management LP Naples, FL50KShares$875,0000.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny23.9KShares$417,4970.0% of portfolio
-
Diadema Partners LP Morristown, NJ7.32KShares$128,1700.04% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K31.69KShares$29,4870.02% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $488M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...